Maxipime (MAXI-peem, cefepime), the first "fourth-generation" injectable cephalosporin
June 1996
Bristol-Myers Squibb is launching Maxipime (MAXI-peem, cefepime), the first "fourth-generation" injectable cephalosporin.
In general, the first-generation agents are primarily active against gram-positive bacteria. Second and third generations have increasing gram-negative coverage...sometimes at the expense of reduced gram-positive activity.
Fourth-generation cephalosporins are considered "broad spectrum" with both gram-negative and gram-positive coverage.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote